Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of UBXN7 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of UBXN7 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of UBXN7 mRNA | CTD | PMID:29097150 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of UBXN7 mRNA | CTD | PMID:26251327 | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of UBXN7 protein | CTD | PMID:34915118 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | UBXN7 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of UBXN7 mRNA | CTD | PMID:28628672 | aflatoxin B1 | increases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of UBXN7 mRNA | CTD | PMID:19770486 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of UBXN7 mRNA | CTD | PMID:25181051 | bisphenol A | increases methylation | ISO | UBXN7 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of UBXN7 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of UBXN7 mRNA | CTD | PMID:30816183 and PMID:34947998 | bisphenol F | multiple interactions | ISO | UBXN7 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of UBXN7 mRNA | CTD | PMID:28628672 | butanal | decreases expression | ISO | UBXN7 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of UBXN7 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | UBXN7 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBXN7 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | UBXN7 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBXN7 mRNA | CTD | PMID:35301059 | caffeine | affects phosphorylation | ISO | UBXN7 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of UBXN7 protein | CTD | PMID:35688186 | CGP 52608 | multiple interactions | ISO | UBXN7 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to UBXN7 gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of UBXN7 mRNA | CTD | PMID:37019170 | coumarin | decreases phosphorylation | ISO | UBXN7 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of UBXN7 protein | CTD | PMID:35688186 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of UBXN7 mRNA | CTD | PMID:23640034 | dexamethasone | multiple interactions | ISO | UBXN7 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of UBXN7 mRNA | CTD | PMID:28628672 | doxorubicin | increases expression | ISO | UBXN7 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of UBXN7 mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | ISO | UBXN7 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of UBXN7 protein | CTD | PMID:23301498 | ethanol | affects splicing | ISO | Ubxn7 (Mus musculus) | 6480464 | Ethanol affects the splicing of UBXN7 mRNA | CTD | PMID:30319688 | FR900359 | increases phosphorylation | ISO | UBXN7 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of UBXN7 protein | CTD | PMID:37730182 | genistein | increases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | Genistein results in increased expression of UBXN7 mRNA | CTD | PMID:32186404 | genistein | decreases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | Genistein results in decreased expression of UBXN7 mRNA | CTD | PMID:32186404 | hydrogen peroxide | multiple interactions | ISO | Ubxn7 (Mus musculus) | 6480464 | N-(oxo-5 more ... | CTD | PMID:31494107 | hydrogen peroxide | increases phosphorylation | ISO | Ubxn7 (Mus musculus) | 6480464 | Hydrogen Peroxide results in increased phosphorylation of UBXN7 protein | CTD | PMID:31494107 | indometacin | multiple interactions | ISO | UBXN7 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of UBXN7 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | UBXN7 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of UBXN7 protein | CTD | PMID:32959892 | maneb | multiple interactions | ISO | Ubxn7 (Mus musculus) | 6480464 | [Paraquat co-treated with Maneb] affects the expression of UBXN7 mRNA | CTD | PMID:22563483 | methyl methanesulfonate | increases expression | ISO | UBXN7 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of UBXN7 mRNA | CTD | PMID:23649840 | paraquat | multiple interactions | ISO | Ubxn7 (Mus musculus) | 6480464 | [Paraquat co-treated with Maneb] affects the expression of UBXN7 mRNA | CTD | PMID:22563483 | paraquat | increases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | Paraquat results in increased expression of UBXN7 mRNA | CTD | PMID:22563483 | pentanal | decreases expression | ISO | UBXN7 (Homo sapiens) | 6480464 | pentanal results in decreased expression of UBXN7 mRNA | CTD | PMID:26079696 | phenobarbital | increases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of UBXN7 mRNA | CTD | PMID:19270015 | potassium dichromate | increases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of UBXN7 mRNA | CTD | PMID:23608068 | pyridaben | increases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | pyridaben results in increased expression of UBXN7 mRNA | CTD | PMID:22563483 | quercetin | increases phosphorylation | ISO | UBXN7 (Homo sapiens) | 6480464 | Quercetin results in increased phosphorylation of UBXN7 protein | CTD | PMID:35688186 | SB 431542 | multiple interactions | ISO | UBXN7 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of UBXN7 protein | CTD | PMID:37664457 | sunitinib | increases expression | ISO | UBXN7 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of UBXN7 mRNA | CTD | PMID:31533062 | tert-butyl hydroperoxide | decreases expression | ISO | UBXN7 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of UBXN7 mRNA | CTD | PMID:15336504 | tert-butyl hydroperoxide | increases expression | ISO | UBXN7 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of UBXN7 mRNA | CTD | PMID:15336504 | tetrachloroethene | increases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of UBXN7 mRNA | CTD | PMID:28973375 | titanium dioxide | decreases expression | ISO | Ubxn7 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of UBXN7 mRNA | CTD | PMID:23557971 | urethane | increases expression | ISO | UBXN7 (Homo sapiens) | 6480464 | Urethane results in increased expression of UBXN7 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | UBXN7 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of UBXN7 mRNA | CTD | PMID:23179753 | |